ASYMMETRIC HYDROGENATION
Product Description
KD Pharma Group SA
-
CH -
2021On CPHI since
-
250 - 499Employees
Company types
Primary activities
Categories
KD Pharma Group SA
-
CH
-
2021On CPHI since
-
250 - 499Employees
Company types
Primary activities
More Products from KD Pharma Group SA (12)
-
Product Core Technologies and Services
• API / GMP Manufacturing • Rapid Process Development, Flawless Upscaling, and Economy of Scale-Production • Simulated-Moving Bed (SMB) Chromatography • Heterocyclic, Hazardous and Malodorous Chemistries • Organometallic and Cryogenic Chemistry • Transition-Metal Catalysis • High-Pressur... -
Product Fine Chemicals
SPECIAL TECHNOLOGIES AND REACTIONS
Special Technologies
• High-pressure reactions up to 64 bar: H2, CO, NH3, Amines, CO2 • Cryogenic: -80°C • Supercritical Fluid Chromatography (SFC), Simulated Moving Bed Chromatography (SMB) • Ultra low vacuum distillation • ... -
Product CONTRACT MANUFACTURING - SMALL MOLECULES
KD Pharma’s professional expertise, state-of-the-art assets and proven track record in regulatory compliance allow us to become your preferred CDMO solutions partner.
Your Agile Experts
• Responsive to our customers’ needs in a more dynamic customer-centric way • Adaptive to the most diverse re... -
Product API & INTERMEDIATES
The CDMO Division of KD Pharma excels in the production of drug intermediates and API drug substances. We offer our customers the full spectrum of drug services: • R&D development material for preclinical studies • Pilot plant for phase I, II and III supplies • Large scale p... -
Product HIGH-PRESSURE HYDROGENATION
Sophisticated reduction technologies:The CDMO Division of KD Pharma operates highly corrosion resistant Inconel® facilities to perform hydrogenation under pressure up to 64 bar (928 psig) and temperatures up to 150°C from lab to industrial scale (4 m3). Both homogeneous as well as heterogene... -
Product SIMULATED MOVING BED CHROMATOGRAPHY (SMB)
KD Pharma is a contract manufacturer that develops products in the pharmaceutical space by employing state-of-the-art technology. Since its inception in 1988, KD Pharma has focused on utilizing cutting edge technologies to develop and manufacture exceptional quality APIs. These twin pillars of technology a... -
Product CARBONYLATION / C-C & C-N COUPLING
We extensively address the specific needs of the pharmaceutical, food, cosmetics, agrochemicals and specialty chemicals industries with our capabilities in Transition Metal Catalysis (TMC). Complex active pharmaceutical ingredients (API’s) are often stereochemically demanding: use of modern synthetic metho... -
Product CYANATION OF ANILINES AND HALOAROMATICS
KD Pharma has been performing a number of different cyanation reactions on industrial scale. Among those, cost efficient and selective cyanation of amino-aromatics through diazotization and subsequent Sandmeyer reaction is standard practice.In addition, Copper(II)-promoted direct cyanation of haloaromatics... -
Product DISTILLATION
Modern distillation technologies:The CDMO Division of KD Pharma operates different multifunctional distillation facilities from pilot scale to industrial scale volumes. In combination with KD Pharma’s outstanding and highly flexible manufacturing capabilities, we can produce various high purity liquid prod... -
Product Functional Polymers
The CDMO Division of KD Pharma offer well-established experience in the chemical functionalization of custom and designer polymers. We are specialized in polymer production used in sensitive applications, where a high level of confidence in production consistency, regulatory compliance and technical perfor... -
Product HAZARDOUS AND MALODOROUS CHEMISTRIES
The CDMO Division of KD Pharma have years of experience with challenging chemistries involving toxicity, odor, industrial hygiene and environmental protection. We are experts handling these problematic chemistries and have over time made appropriate provisions to control these hazards as to work in fu... -
Product Lipids APIs and Intermediates
KD Pharma is the largest producer of omega-3 based APIs. Its unique technology mix produces Omega-3 drug substances of the highest quality and purity. We offer concentrates with EPA up to 99% purity, DHA up to 95% purity, and can custom manufacture concentrates of almost any other fatty acid.EPA fatty acid...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance